101 related articles for article (PubMed ID: 6348011)
1. Immunochemical identification of the cell surface bound leucine aminopeptidase, the target enzyme for the immunostimulant bestatin.
Leyhausen G; Gramzow M; Zahn RK; Steffen R; Umezawa H; Müller WE
J Antibiot (Tokyo); 1983 Jun; 36(6):728-34. PubMed ID: 6348011
[TBL] [Abstract][Full Text] [Related]
2. Identification and properties of the cell membrane bound leucine aminopeptidase interacting with the potential immunostimulant and chemotherapeutic agent bestatin.
Leyhausen G; Schuster DK; Vaith P; Zahn RK; Umezawa H; Falke D; Müller WE
Biochem Pharmacol; 1983 Mar; 32(6):1051-7. PubMed ID: 6838651
[TBL] [Abstract][Full Text] [Related]
3. Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.
Weissmann N; Leyhausen G; Maidhof A; Tanaka W; Umezawa H; Müller WE
J Antibiot (Tokyo); 1985 Jun; 38(6):772-8. PubMed ID: 4019321
[TBL] [Abstract][Full Text] [Related]
4. Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis.
Burley SK; David PR; Lipscomb WN
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):6916-20. PubMed ID: 1871107
[TBL] [Abstract][Full Text] [Related]
5. Aminopeptidase activity in human nasal mucosa.
Ohkubo K; Baraniuk JN; Hohman R; Merida M; Hersh LB; Kaliner MA
J Allergy Clin Immunol; 1998 Nov; 102(5):741-50. PubMed ID: 9819290
[TBL] [Abstract][Full Text] [Related]
6. Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cells.
Müller WE; Schuster DK; Zahn RK; Maidhof A; Leyhausen G; Falke D; Koren R; Umezawa H
Int J Immunopharmacol; 1982; 4(5):393-400. PubMed ID: 6982243
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of leucyl aminopeptidase in Plasmodium falciparum parasites. Target for the antimalarial activity of bestatin.
Gardiner DL; Trenholme KR; Skinner-Adams TS; Stack CM; Dalton JP
J Biol Chem; 2006 Jan; 281(3):1741-5. PubMed ID: 16286469
[TBL] [Abstract][Full Text] [Related]
8. Use of azidobestatin as a photoaffinity label to identify the active site peptide of leucine aminopeptidase.
Taylor A; Peltier CZ; Jahngen EG; Laxman E; Szewczuk Z; Torre FJ
Biochemistry; 1992 Apr; 31(16):4141-50. PubMed ID: 1567860
[TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization of Babesia bovis M17 Leucine Aminopeptidase and Inhibition of Babesia Growth by Bestatin.
Aboge GO; Cao S; Terkawi MA; Masatani T; Goo Y; AbouLaila M; Nishikawa Y; Igarashi I; Suzuki H; Xuan X
J Parasitol; 2015 Oct; 101(5):536-41. PubMed ID: 26057618
[TBL] [Abstract][Full Text] [Related]
10. Induction of DNA polymerase alpha and terminal deoxynucleotidyl transferase in the human lymphoblastoid cell line Molt-4 by the immunomodulator bestatin.
Leyhausen G; Dippold W; Zahn RK; Meyer zum Büschenfelde KH; Umezawa H; Müller WE
Immunopharmacology; 1984 Jun; 7(3-4):151-7. PubMed ID: 6590537
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429
[TBL] [Abstract][Full Text] [Related]
12. The role of bestatin, an inhibitor of cell surface proteases, in the interaction of serum with untransformed cells in culture.
Koren R; Bercovitz H; Umezawa H; Müller WE
J Antibiot (Tokyo); 1981 Jan; 34(1):90-4. PubMed ID: 7251513
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibitory effect of bestatin on choriocarcinoma cell lines in vitro.
Ino K; Goto S; Kosaki A; Nomura S; Asada E; Misawa T; Furuhashi Y; Mizutani S; Tomoda Y
Biotherapy; 1991; 3(4):351-7. PubMed ID: 1786199
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of a membrane-bound enkephalin-degrading aminopeptidase by bestatin analogs.
Shimamura M; Hazato T; Hachisu M; Katayama T
J Neurochem; 1984 Sep; 43(3):888-90. PubMed ID: 6431055
[TBL] [Abstract][Full Text] [Related]
15. Identification of cytosolic leucyl aminopeptidase (EC 3.4.11.1) as the major cysteinylglycine-hydrolysing activity in rat liver.
Jösch C; Klotz LO; Sies H
Biol Chem; 2003 Feb; 384(2):213-8. PubMed ID: 12675513
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin.
Nankya-Kitaka MF; Curley GP; Gavigan CS; Bell A; Dalton JP
Parasitol Res; 1998 Jul; 84(7):552-8. PubMed ID: 9694371
[TBL] [Abstract][Full Text] [Related]
17. Re-refinement of the X-ray crystal structure of bovine lens leucine aminopeptidase complexed with bestatin.
Kim H; Burley SK; Lipscomb WN
J Mol Biol; 1993 Apr; 230(3):722-4. PubMed ID: 8478928
[TBL] [Abstract][Full Text] [Related]
18. Aminopeptidase activities on the surface of mammalian cells.
Aoyagi T; Suda H; Nagai M; Ogawa K; Suzuki J
Biochim Biophys Acta; 1976 Nov; 452(1):131-43. PubMed ID: 990309
[TBL] [Abstract][Full Text] [Related]
19. Effect of ubenimex (Bestatin) on the cell growth and phenotype of HL-60 and HL-60R cell lines: up-and down-regulation of CD13/aminopeptidase N.
Imamura N; Kimura A
Leuk Lymphoma; 2000 May; 37(5-6):663-7. PubMed ID: 11042531
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of bovine lens leucine aminopeptidase by bestatin: number of binding sites and slow binding of this inhibitor.
Taylor A; Peltier CZ; Torre FJ; Hakamian N
Biochemistry; 1993 Jan; 32(3):784-90. PubMed ID: 8422382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]